amsacrine has been researched along with Minimal Disease, Residual in 4 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The load of minimal residual disease prior to transplantation appears to be predictive for outcome in this very poor-prognosis subgroup of ALL." | 1.33 | Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children. ( Escherich, G; Hassenpflug, WA; Horstmann, MA; Janka, G; Kabisch, H; zur Stadt, U, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meur, GL | 1 |
| Plesa, A | 1 |
| Larcher, MV | 1 |
| Fossard, G | 1 |
| Barraco, F | 1 |
| Loron, S | 1 |
| Balsat, M | 1 |
| Ducastelle-Leprêtre, S | 1 |
| Gilis, L | 1 |
| Thomas, X | 1 |
| Ghesquières, H | 1 |
| Tigaud, I | 1 |
| Hayette, S | 1 |
| Huet, S | 1 |
| Sujobert, P | 1 |
| Renault, M | 1 |
| Thérèse, RM | 1 |
| Michallet, M | 1 |
| Labussière-Wallet, H | 1 |
| Heiblig, M | 1 |
| Wernstedt, P | 1 |
| Brune, M | 1 |
| Andersson, PO | 1 |
| Gustavsson, B | 1 |
| Stockelberg, D | 1 |
| Wadenvik, H | 1 |
| Horstmann, MA | 1 |
| Hassenpflug, WA | 1 |
| zur Stadt, U | 1 |
| Escherich, G | 1 |
| Janka, G | 1 |
| Kabisch, H | 1 |
| Gore, SD | 1 |
| Burke, PJ | 1 |
| Weng, LJ | 1 |
4 other studies available for amsacrine and Minimal Disease, Residual
| Article | Year |
|---|---|
Impact on Outcome of Minimal Residual Disease after Hematopoietic Stem Cell Transplantation with Fludarabine, Amsacrine, and Cytosine Arabinoside-Busulfan Conditioning: A Retrospective Monocentric Study.
Topics: Amsacrine; Busulfan; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, | 2023 |
Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia.
Topics: Adult; Amsacrine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; | 2002 |
Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.
Topics: Adolescent; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Comb | 2005 |
Impact of exogenous growth factors on proliferation and chemosensitivity of minimal residual acute myeloid leukemia.
Topics: Acute Disease; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; D | 1998 |